glp 1 in pregnancy Use of GLP-1 drugs early should not cause alarm, analysis suggests How safe are GLP-1R agonists

The clinical outcomes data is robust and the benefit-risk profile, in appropriate patient populations, is well established

For people using GLP-1 drugs for weight loss, 45% plan to use them long-term, but more (51%) are likely to go on and off based on their needs

The key is choosing whole, unprocessed sources and keeping portions small

However, the renal beneficial effect of SGLT2-i has been definitely reported in recent cardiovascular outcome clinical trials and further confirmed in CREDENCE, DAPA-CKD, EMPA-KIDNEY, which investigated renal outcomes as primary endpoints also in non-diabetic patients with chronic kidney disease (48)

It is arguably the most important section in this entire guide